Li Wei
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Risk of adverse effects of the concomitant use of statins with calcium channel blockers: a systematic review and meta-analysis.
Journal: Postgraduate medicine
Published: June 26, 2026
Fluoxetine-associated adverse event signals with a focus on seizure: A study based on the FAERS database, network pharmacology, and molecular docking.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: April 28, 2026
Incidence of type 2 diabetes mellitus in men receiving finasteride and tamsulosin: a cross-validation cohort study using data from China and UK populations.
Journal: Diabetes research and clinical practice
Published: February 12, 2026
Research progress on Alzheimer's disease vaccines: from Aβ-targeted approaches to clinical translation.
Journal: Frontiers in aging
Published: January 23, 2026
Abrupt discontinuation and tapering of antipsychotics in older adults with dementia: a target trial emulation study.
Journal: The lancet. Healthy longevity
Published: November 16, 2025
Long-term outcomes associated with istradefylline versus catechol-O-methyltransferase inhibitors in patients with Parkinson's disease: a nationwide real-world cohort study.
Journal: Parkinsonism & related disorders
Published: October 28, 2025
Risk of fracture with gabapentinoid treatment in older adults: a multinational population-based study.
Journal: The lancet. Healthy longevity
Published: September 15, 2025
Effects of Warfarin on the Risks of Mortality, Acute Heart Failure, and Infection Resolution in Patients With Infective Endocarditis: A Target Trial Emulation.
Journal: Journal of the American Heart Association
Published: July 17, 2025
A Methodological Review of Simulation Studies Published in Pharmacoepidemiology and Drug Safety.
Journal: Pharmacoepidemiology and drug safety
Published: May 19, 2025
Corrigendum to "Risk of secondary myelodysplastic syndromes and acute myeloid leukaemia following poly(ADP-ribose) polymerase inhibitor treatment for advanced-stage ovarian cancer: A retrospective cohort study" [Eur J Cancer 222 (2025) 115472].
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 17, 2025
Risk of secondary myelodysplastic syndromes and acute myeloid leukaemia following poly(ADP-ribose) polymerase inhibitor treatment for advanced-stage recurrent ovarian cancer: A retrospective cohort study in England.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 17, 2025
Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: December 06, 2024
Last Updated: 09/26/2026